Mean (SE) concentrations of lipid phase antioxidants and total cholesterol in the plasma of patients with cystic fibrosis during an exacerbation and after antibiotic treatment and in controls
| Patients (n = 12) | Controls (n = 12) | ||||
|---|---|---|---|---|---|
| Exacerbation | After treatment | ||||
| Retinol (nmol/mmol cholesterol) | 328 (140)a1 | 480 (170)b2 | 565 (201) | ||
| α-carotene (nmol/mmol cholesterol) | 5.6 (3.6) | 6.2 (4.3)c2 | 17.1 (4.5) | ||
| β-carotene (nmol/mmol cholesterol) | 24.0 (16.4)d1 | 31.6 (15.8)c1,c2 | 76.8 (25.6) | ||
| α-tocopherol (nmol/mmol cholesterol) | 4802 (1880) | 5641 (1845)a2 | 4717 (1618) | ||
| γ-tocopherol (nmol/mmol cholesterol) | 326 (85) | 390 (124) | 402 (104) | ||
| Luteine (nmol/mmol cholesterol) | 20.6 (8.7)d1 | 24.3 (11.2)d1 | 71.0 (29.6) | ||
| Lycopene (nmol/mmol cholesterol) | 20.4 (8.7)d1 | 28.6 (25.5)d1,a2 | 110.5 (31.3) | ||
| Ubiquinol 10 (nmol/mmol cholesterol) | 142 (36) | 135 (35) | 146 (21) | ||
| Total cholesterol (mmol/l) | 3.4 (0.8)d1 | 3.7 (1.2)a1 | 4.9 (0.8) | ||
3-a p<0.05, bp<0.01,cp<0.005, dp<0.001, 1versus control, 2versus first patient observation.